Value of Low Dose Combination Treatment with Blood Pressure Lowering Drugs: Analysis of 354 Randomised Trials

Overview

Journal BMJ

Specialty General Medicine

Date 2003 Jun 28

PMID 12829555

Citations 373

Authors

M R Law

N J Wald

J K Morris

R E Jordan

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the average reduction in blood pressure, prevalence of adverse effects, and reduction in risk of stroke and ischaemic heart disease events produced by the five main categories of blood pressure lowering drugs according to dose, singly and in combination.

Design: Meta-analysis of 354 randomised double blind placebo controlled trials of thiazides, beta blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists, and calcium channel blockers in fixed dose.

Subjects: 40,000 treated patients and 16,000 patients given placebo.

Main Outcome Measures: Placebo adjusted reductions in systolic and diastolic blood pressure and prevalence of adverse effects, according to dose expressed as a multiple of the standard (recommended) doses of the drugs.

Results: All five categories of drug produced similar reductions in blood pressure. The average reduction was 9.1 mm Hg systolic and 5.5 mm Hg diastolic at standard dose and 7.1 mm Hg systolic and 4.4 mm Hg diastolic (20% lower) at half standard dose. The drugs reduced blood pressure from all pretreatment levels, more so from higher levels; for a 10 mm Hg higher blood pressure the reduction was 1.0 mm Hg systolic and 1.1 mm Hg diastolic greater. The blood pressure lowering effects of different categories of drugs were additive. Symptoms attributable to thiazides, beta blockers, and calcium channel blockers were strongly dose related; symptoms caused by ACE inhibitors (mainly cough) were not dose related. Angiotensin II receptor antagonists caused no excess of symptoms. The prevalence of symptoms with two drugs in combination was less than additive. Adverse metabolic effects (such as changes in cholesterol or potassium) were negligible at half standard dose.

Conclusions: Combination low dose drug treatment increases efficacy and reduces adverse effects. From the average blood pressure in people who have strokes (150/90 mm Hg) three drugs at half standard dose are estimated to lower blood pressure by 20 mm Hg systolic and 11 mm Hg diastolic and thereby reduce the risk of stroke by 63% and ischaemic heart disease events by 46% at age 60-69.

Citing Articles

Breastfeeding and cardiometabolic risk factors in adulthood: results from the Pelotas (Brazil) birth cohort, 1982.

Lima N, Motta J, Horta B Cad Saude Publica. 2025; 41(1):e00044224.

PMID: 40008705 PMC: 11863628. DOI: 10.1590/0102-311XEN044224.

Health-promoting text messages to patients with hypertension-A randomized controlled trial in Swedish primary healthcare.

Borgstrom Bolmsjo B, Bredfelt J, Calling S, Glock H, Milos Nymberg V, Bengtsson Bostrom K PLoS One. 2025; 20(2):e0314868.

PMID: 39937817 PMC: 11819501. DOI: 10.1371/journal.pone.0314868.

Cost-Effectiveness of a Polypill for Cardiovascular Disease Prevention in an Underserved Population.

Kohli-Lynch C, Moran A, Kazi D, Bibbins-Domingo K, Jordan N, French D JAMA Cardiol. 2025; 10(3):224-233.

PMID: 39775718 PMC: 11904704. DOI: 10.1001/jamacardio.2024.4812.

Effects of High-Intensity Interval Training on Blood Pressure Levels in Hypertensive Patients: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Romero-Vera L, Ulloa-Diaz D, Araya-Sierralta S, Guede-Rojas F, Andrades-Ramirez O, Carvajal-Parodi C Life (Basel). 2025; 14(12.

PMID: 39768368 PMC: 11728122. DOI: 10.3390/life14121661.

Simplified Approach to Managing Newly Diagnosed Patients with Mild-to-Moderate Hypertension in Routine Clinical Practice.

Daskalopoulou S, Papacostas-Quintanilla H, Brzozowska-Villatte R Adv Ther. 2024; 42(2):1108-1130.

PMID: 39731708 PMC: 11787162. DOI: 10.1007/s12325-024-03091-6.

References

FREIS E . Critique of the clinical importance of diurectic-induced hypokalemia and elevated cholesterol level. Arch Intern Med. 1989; 149(12):2640-8. View

Macmahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J . Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990; 335(8692):765-74. DOI: 10.1016/0140-6736(90)90878-9. View

Collins R, Peto R, Macmahon S, Hebert P, Fiebach N, Eberlein K . Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990; 335(8693):827-38. DOI: 10.1016/0140-6736(90)90944-z. View

Israili Z, Hall W . Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med. 1992; 117(3):234-42. DOI: 10.7326/0003-4819-117-3-234. View

Azizi M, Chatellier G, Guyene T, Menard J . Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Circulation. 1995; 92(4):825-34. DOI: 10.1161/01.cir.92.4.825. View

Grimm Jr R, Flack J, Grandits G, Elmer P, Neaton J, Cutler J . Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. JAMA. 1996; 275(20):1549-56. DOI: 10.1001/jama.1996.03530440029033. View

Coulter D, Edwards I . Cough associated with captopril and enalapril. Br Med J (Clin Res Ed). 1987; 294(6586):1521-3. PMC: 1246673. DOI: 10.1136/bmj.294.6586.1521. View

Campion E, Glynn R, DeLabry L . Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987; 82(3):421-6. DOI: 10.1016/0002-9343(87)90441-4. View

Kaplan N, Carnegie A, Raskin P, Heller J, Simmons M . Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia. N Engl J Med. 1985; 312(12):746-9. DOI: 10.1056/NEJM198503213121203. View

10.

Papademetriou V, Price M, Johnson E, Smith M, FREIS E . Early changes in plasma and urinary potassium in diuretic-treated patients with systemic hypertension. Am J Cardiol. 1984; 54(8):1015-9. DOI: 10.1016/s0002-9149(84)80136-8. View

11.

Greenberg G, Brennan P, MIALL W . Effects of diuretic and beta-blocker therapy in the Medical Research Council Trial. Am J Med. 1984; 76(2A):45-51. DOI: 10.1016/0002-9343(84)90956-2. View

12.

Murphy M, Lewis P, Kohner E, SCHUMER B, Dollery C . Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet. 1982; 2(8311):1293-5. DOI: 10.1016/s0140-6736(82)91506-9. View

13.

. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension. Lancet. 1981; 2(8246):539-43. View

14.

Wilkinson P, Issler H, Hesp R, Raftery E . Total body and serum potassium during prolonged thiazide therapy for essential hypertension. Lancet. 1975; 1(7910):759-62. DOI: 10.1016/s0140-6736(75)92432-0. View

15.

Law M, Wald N, Morris J . Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health Technol Assess. 2003; 7(31):1-94. DOI: 10.3310/hta7310. View

16.

Seedat Y . Varying responses to hypotensive agents in different racial groups: black versus white differences. J Hypertens. 1989; 7(7):515-8. DOI: 10.1097/00004872-198907000-00001. View

17.

Papademetriou V, Burris J, Notargiacomo A, FLETCHER R, FREIS E . Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension. Arch Intern Med. 1988; 148(6):1272-6. View

18.

Lawes C, Rodgers A, Bennett D, Parag V, Suh I, Ueshima H . Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003; 21(4):707-16. DOI: 10.1097/00004872-200304000-00013. View

19.

Grimm Jr R, Grandits G, Prineas R, McDONALD R, Lewis C, Flack J . Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension. 1997; 29(1 Pt 1):8-14. DOI: 10.1161/01.hyp.29.1.8. View

20.

Bucher H, Guyatt G, Griffith L, Walter S . The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997; 50(6):683-91. DOI: 10.1016/s0895-4356(97)00049-8. View